Early indicators of prognosis in fulminant hepatic failure.

PubWeight™: 7.43‹?› | Rank: Top 0.1%

🔗 View Article (PMID 2490426)

Published in Gastroenterology on August 01, 1989

Authors

J G O'Grady1, G J Alexander, K M Hayllar, R Williams

Author Affiliations

1: Liver Unit, King's College School of Medicine, London, United Kingdom.

Associated clinical trials:

13C-Methacetin Breath Test for the Prediction of Outcome in ALF (ALF-MBT) | NCT02786836

Articles citing this

(truncated to the top 100)

Liver failure induced by paracetamol. BMJ (1993) 8.18

Liver transplantation (1). N Engl J Med (1989) 4.53

Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology (2009) 3.88

Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94

Liver transplantation after paracetamol overdose. BMJ (1991) 2.81

Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology (2011) 2.61

Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology (2012) 2.26

Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology (2010) 2.26

Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ (1990) 2.18

Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci (2012) 2.08

Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol (2012) 1.91

Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology (2006) 1.83

Paracetamol induced hepatotoxicity. Arch Dis Child (2006) 1.67

Comparison of Prothrombin Time and Aspartate Aminotransferase in Predicting Hepatotoxicity After Acetaminophen Overdose. J Med Toxicol (2016) 1.59

CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure. Gastroenterology (2015) 1.59

An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol (2009) 1.54

Concomitant overdosing of other drugs in patients with paracetamol poisoning. Br J Clin Pharmacol (2002) 1.49

Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45

Acute liver failure. Postgrad Med J (2005) 1.42

Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int (2009) 1.41

Liver transplant center variability in accepting organ offers and its impact on patient survival. J Hepatol (2015) 1.39

Management of acute liver failure. Nat Rev Gastroenterol Hepatol (2009) 1.32

Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. Br J Clin Pharmacol (2011) 1.27

Clinical application of bioartificial liver support systems. Ann Surg (2004) 1.24

Liver transplantation for acute-on-chronic liver failure. Hepatol Int (2009) 1.23

Fulminant hepatic failure caused by tuberculosis. Gut (1995) 1.18

New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17

Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg (2003) 1.15

The study of efficacy of lamivudine in patients with severe acute hepatitis B. Dig Dis Sci (2009) 1.14

Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat (2010) 1.13

Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity. PLoS Negl Trop Dis (2012) 1.13

Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol (2007) 1.12

Acute liver damage and ecstasy ingestion. Gut (1996) 1.11

Serious paracetamol poisoning and the results of liver transplantation. Gut (1994) 1.10

Acute liver failure including acetaminophen overdose. Med Clin North Am (2008) 1.10

Paracetamol hepatotoxicity: how to prevent. J R Soc Med (1997) 1.09

Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut (2005) 1.07

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care (2015) 1.07

Acetaminophen poisoning: an update for the intensivist. Crit Care (2002) 1.07

Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol (1999) 1.06

Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol (2012) 1.05

Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol (2006) 1.05

Acute liver failure: a life-threatening disease. Dtsch Arztebl Int (2011) 1.03

Liver transplantation in the UK. World J Gastroenterol (2001) 1.02

Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol (2012) 1.02

Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection. J Clin Exp Hepatol (2013) 0.98

Liver transplantation: fifty years of experience. World J Gastroenterol (2014) 0.98

Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur J Clin Pharmacol (2008) 0.97

Age and paracetamol self-poisoning. Gut (2005) 0.97

Acute Liver Failure Caused by Amanita phalloides Poisoning. Int J Hepatol (2012) 0.95

Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PLoS One (2012) 0.95

Liver transplantation. Gut Liver (2009) 0.93

Liver transplantation--challenges for the future. West J Med (1991) 0.92

Hepatotoxic effects of therapies for tuberculosis. Nat Rev Gastroenterol Hepatol (2010) 0.92

Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci (2008) 0.92

King's College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children. J Pediatr (2012) 0.92

Aetiology and outcome of acute liver failure. HPB (Oxford) (2009) 0.91

Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut (1992) 0.91

Natural course of fulminant hepatic failure: the scenario in Bangladesh and the differences from the west. Saudi J Gastroenterol (2009) 0.91

Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy. Gastroenterol Res Pract (2009) 0.91

Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol (2009) 0.90

Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury. Hepatology (2015) 0.90

Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int (2014) 0.89

Liver transplantation for bile duct injury after open and laparoscopic cholecystectomy. Br J Surg (2013) 0.88

A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis. J Gastroenterol (2009) 0.88

Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (N Y) (2012) 0.88

Indications and contraindications for liver transplantation. Int J Hepatol (2011) 0.88

Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf (2013) 0.88

Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States. Clin Gastroenterol Hepatol (2009) 0.87

Orthotopic liver transplantation for fulminant hepatitis B. World J Gastroenterol (2000) 0.87

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: a retrospective study. Comp Hepatol (2008) 0.87

Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig Dis Sci (2011) 0.87

Outcome of acute liver failure in the elderly. Liver Transpl (2009) 0.87

Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant (2008) 0.86

Algorithm to determine the outcome of patients with acute liver failure: a data-mining analysis using decision trees. J Gastroenterol (2012) 0.86

Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci (2000) 0.86

Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol (2010) 0.86

Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut (1999) 0.85

Fulminant hepatic failure in an African setting: etiology, clinical course, and predictors of mortality. Dig Dis Sci (2007) 0.85

Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices. Sci Rep (2014) 0.85

Prediction of hepatic encephalopathy development in patients with severe acute hepatitis. Dig Dis Sci (2006) 0.84

Acute liver failure. Wien Klin Wochenschr (2004) 0.84

Variation in access to the liver transplant waiting list in the United States. Transplantation (2014) 0.83

Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax (1995) 0.83

Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol (2011) 0.83

Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation. Liver Int (2009) 0.83

Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure. Gastroenterol Rep (Oxf) (2014) 0.83

Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis. Hepatol Int (2008) 0.83

Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterol (2009) 0.83

The role of etiology in the hyperamylasemia of acute liver failure. Am J Gastroenterol (2009) 0.83

Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy. Dig Dis Sci (2006) 0.82

Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol (2014) 0.82

Survival predictors in patients treated with a molecular adsorbent recirculating system. World J Gastroenterol (2009) 0.82

Liver regeneration in relationship to acute liver failure. Gut (1991) 0.81

Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience. Dig Dis Sci (2006) 0.81

Liver transplantation organ allocation between Child and MELD. Wien Med Wochenschr (2006) 0.81

Transplantation after blunt trauma to the liver: a valuable option or just a "waste of organs"? Eur J Med Res (2010) 0.81

Optimizing management in autoimmune hepatitis with liver failure at initial presentation. World J Gastroenterol (2011) 0.81

Acute liver failure in pregnancy: Challenges and management. Indian J Anaesth (2015) 0.81

Acute liver failure and liver transplantation. Intractable Rare Dis Res (2013) 0.81

Articles by these authors

Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26

Cost analysis of early discharge after hip fracture. BMJ (1993) 6.64

Deaths from low dose paracetamol poisoning. BMJ (1998) 6.63

Anti-tuberculous therapy and acute liver failure. Lancet (1995) 6.27

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med (2000) 6.07

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05

Acute liver failure: redefining the syndromes. Lancet (1993) 4.99

Vulnerability genes or plasticity genes? Mol Psychiatry (2009) 4.96

Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet (1990) 4.57

Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. Lancet (1971) 4.49

Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38

Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet (1990) 4.27

Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10

Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect (1999) 4.07

Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (1972) 3.90

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78

Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet (1974) 3.61

Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess (2007) 3.40

Structured patient education: the diabetes X-PERT Programme makes a difference. Diabet Med (2006) 3.36

Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med (1978) 3.28

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med (1992) 3.24

NHLBI Family Heart Study: objectives and design. Am J Epidemiol (1996) 3.21

Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature (1974) 3.17

Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin Exp Immunol (1977) 3.13

Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09

Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09

Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription. Nucleic Acids Res (1990) 3.08

Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet (1998) 3.06

Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04

Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet (1973) 2.98

Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98

Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut (1995) 2.96

Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94

More donor organs for transplantation. Elective ventilation proposals. J R Coll Physicians Lond (1993) 2.91

Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med (1973) 2.88

Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J (1971) 2.86

The arthropathy of idiopathic haemochromatosis. Q J Med (1968) 2.85

Hepatitis B virus infection in medical and health care personnel. Br Med J (Clin Res Ed) (1982) 2.85

Liver transplantation after paracetamol overdose. BMJ (1991) 2.81

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol (1997) 2.78

Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76

Liver in Felty's syndrome. Br Med J (1970) 2.75

Hepatic damage and death from overdose of paracetamol. Lancet (1973) 2.70

Extrahepatic biliary atresia versus neonatal hepatitis. Review of 137 prospectively investigated infants. Arch Dis Child (1976) 2.67

Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67

Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med (1991) 2.65

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62

Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology (1988) 2.60

Treatment of hepatic encephalopathy. N Engl J Med (1997) 2.60

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol (1994) 2.58

Liver transplantation. Curr Probl Surg (1979) 2.57

Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet (1977) 2.53

Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut (1998) 2.51

Orthotopic liver transplantation: the first 60 patients. Br Med J (1977) 2.50

A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50

The systemic inflammatory response syndrome in acute liver failure. Hepatology (2000) 2.47

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45

Attentional bias in anxiety and depression: the role of awareness. Br J Clin Psychol (1995) 2.43

Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet (1994) 2.42

Developing and deploying a patient safety program in a large health care delivery system: you can't fix what you don't know about. Jt Comm J Qual Improv (2001) 2.42

Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41

Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med (1995) 2.41

1 -Antitrypsin deficiency and neonatal hepatitis. Br Med J (1972) 2.40

General practice orthopaedic outpatient referrals in North Staffordshire. Br Med J (Clin Res Ed) (1983) 2.38

Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet (1974) 2.37

Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations. Adv Exp Med Biol (1997) 2.35

Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32

Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol (1992) 2.31

Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31

Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet (1982) 2.30

Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet (1970) 2.25

Cytomegalovirus hepatitis in the adult. Lancet (1967) 2.20

Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ (1990) 2.18

Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet (1973) 2.17

Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. Br Med J (Clin Res Ed) (1986) 2.16

Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care (1999) 2.16

Portal hypertension in idiopathic tropical splenomegaly. Lancet (1966) 2.16

Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet (1968) 2.14

Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem (1989) 2.14

Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12

A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology (1995) 2.11

H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet (1977) 2.10

Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure. Br Med J (1973) 2.09

Arthropathy of haemochromatosis. Clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis (1970) 2.09

Detection, treatment, and follow up of women with Chlamydia trachomatis infection seeking abortion in inner city general practices. BMJ (1989) 2.08

Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases. Transplantation (1977) 2.08

Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet (1971) 2.08

Cell-mediated immune responses in chronic liver diseases. Br Med J (1972) 2.05

Inheritance and expression of chimeric genes in the progeny of transgenic maize plants. Biotechnology (N Y) (1990) 2.05

Chondrocalcinosis and arthropathy: studies in haemochromatosis and in idiopathic chondrocalcinosis. Q J Med (1970) 2.03

Development and importance of health needs assessment. BMJ (1998) 2.03

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 2.02

Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00

Liver transplantation in man: the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology (1973) 1.99

Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut (1993) 1.98